Efficacy study of intranasal dexmedetomidine for pediatric sedation

Adequate sedation with single-dose Intranasal dexmedetomidine in pediatric patients undergoing echocardiography: a dose-response study in different age groups

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-16009842

Enrollment

Unknown

Registered

2016-11-13

Start date

2016-11-14

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation for congenital heart disease

Interventions

3 groups:The sequential method of Intranasal dexmedetomidine

Eligibility

Sex/Gender

All

Age

1 Years to 3 Years

Inclusion criteria

Inclusion criteria: Children with simple congenital heart disease (including atrial septal defect, ventricular septal defect, Patent ductus arteriosus, patent foramen ovale, atrial septal defect with ventricular septal defect) Children who did not undergo surgery, aged 0-36 months

Exclusion criteria

Exclusion criteria: Children with complex congenital heart disease, children with normal echocardiography result, children who underwent surgery

Design outcomes

Primary

Measure	Time frame
MOAA/S score;Aldrete score;	—

Secondary

Measure	Time frame
oxygen saturation;heart rate;	—

Countries

China

Contacts

Public ContactTu Shengfen

Children's Hospital Affiliated Chongqing Medical University

519194496@QQ.COM+86 13983416114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026